Pfizer Quietly Suspends Patient Enrollment for Early Stage Tumor Study
This study has suspended participant recruitment.
Further study details as provided by Pfizer:
Primary Outcome Measures:
* Number of participants with Dose-limiting toxicities (DLT) {Part1} [ Time Frame: Day 1 up to Day 21 ]
* First cycle DLTs in order to determine maximum tolerated dose
Further study details as provided by Pfizer:
Primary Outcome Measures:
* Number of participants with Dose-limiting toxicities (DLT) {Part1} [ Time Frame: Day 1 up to Day 21 ]
* First cycle DLTs in order to determine maximum tolerated dose